DK1390042T3 - System for administration af et lægemiddel omfattende tetrahydroxyleret östrogen til anvendelse i hormonal svangerskabsforebyggelse - Google Patents

System for administration af et lægemiddel omfattende tetrahydroxyleret östrogen til anvendelse i hormonal svangerskabsforebyggelse

Info

Publication number
DK1390042T3
DK1390042T3 DK02738961T DK02738961T DK1390042T3 DK 1390042 T3 DK1390042 T3 DK 1390042T3 DK 02738961 T DK02738961 T DK 02738961T DK 02738961 T DK02738961 T DK 02738961T DK 1390042 T3 DK1390042 T3 DK 1390042T3
Authority
DK
Denmark
Prior art keywords
administering
drug
hormonal contraception
tetrahydroxylated estrogen
tetrahydroxylated
Prior art date
Application number
DK02738961T
Other languages
English (en)
Inventor
Christian Franz Holinka
Bennink Herman Jan Ti Coelingh
Evert Johannes Bunschoten
Original Assignee
Pantarhei Bioscience Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP01201945A external-priority patent/EP1293210B1/en
Application filed by Pantarhei Bioscience Bv filed Critical Pantarhei Bioscience Bv
Application granted granted Critical
Publication of DK1390042T3 publication Critical patent/DK1390042T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK02738961T 2001-05-23 2002-05-23 System for administration af et lægemiddel omfattende tetrahydroxyleret östrogen til anvendelse i hormonal svangerskabsforebyggelse DK1390042T3 (da)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
EP01201946 2001-05-23
EP01201945A EP1293210B1 (en) 2001-05-23 2001-05-23 Means and method for hormonal contraception
EP01201947 2001-05-23
EP01204377 2001-11-15
EP02075695 2002-02-21
PCT/NL2002/000331 WO2002094279A1 (en) 2001-05-23 2002-05-23 Drug delivery system comprising a tetrahidroxilated estrogen for use in hormonal contraception

Publications (1)

Publication Number Publication Date
DK1390042T3 true DK1390042T3 (da) 2008-03-31

Family

ID=27513107

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02738961T DK1390042T3 (da) 2001-05-23 2002-05-23 System for administration af et lægemiddel omfattende tetrahydroxyleret östrogen til anvendelse i hormonal svangerskabsforebyggelse

Country Status (12)

Country Link
US (1) US7732430B2 (da)
EP (1) EP1390042B1 (da)
CA (1) CA2448278C (da)
CY (2) CY1108093T1 (da)
DE (1) DE60223795T2 (da)
DK (1) DK1390042T3 (da)
ES (1) ES2296943T3 (da)
FR (1) FR21C1033I2 (da)
LU (1) LUC00213I2 (da)
NL (1) NL301115I2 (da)
PT (1) PT1390042E (da)
WO (1) WO2002094279A1 (da)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI1556058T1 (sl) 2002-10-23 2008-02-29 Pantarhei Bioscience Bv Farmacevtski sestavki, ki obsegajo estetrolne derivate, za uporabo pri zdravljenju raka
US20060211669A1 (en) 2002-11-08 2006-09-21 Verhaar Mark T Synthesis of estetrol via estrone derived steroids
EA025511B1 (ru) 2011-06-01 2016-12-30 Эстетра С.П.Р.Л. Способ получения промежуточных соединений эстетрола
CN107266514A (zh) 2011-06-01 2017-10-20 埃斯特拉私人有限责任公司 用于产生雌四醇中间体的方法
EP2383279A1 (en) 2011-07-19 2011-11-02 Pantarhei Bioscience B.V. Process for the preparation of estetrol
KR102033187B1 (ko) * 2011-07-19 2019-10-16 판타레이 바이오사이언스 비.브이. 디하이드로에피안드로스테론(ｄｈｅａ)을 함유하는 정제
PT2741824T (pt) * 2011-08-11 2017-07-06 Estetra Sprl Utilização de estetrol como contracetivo de emergência
WO2013034780A2 (en) 2012-12-20 2013-03-14 Crystal Pharma, S.A.U. Process for the preparation of estetrol and related compounds
JP6254289B2 (ja) 2013-09-18 2017-12-27 クリスタル ファルマ、エセ、ア、ウＣｒｙｓｔａｌ Ｐｈａｒｍａ，Ｓ．Ａ．Ｕ． エステトロールの製造プロセス
NZ720906A (en) 2013-12-12 2022-04-29 Estetra Sprl Orally disintegrating solid dosage unit containing an estetrol component
EP3310346B1 (en) 2015-06-18 2021-03-24 Estetra SPRL Orodispersible tablet containing estetrol
DK3310345T3 (da) 2015-06-18 2021-05-25 Estetra Sprl Orodispersibel tablet indeholdende estetrol
EA035687B1 (ru) 2015-06-18 2020-07-27 Эстетра Спрл Диспергируемая в полости рта единица дозирования, содержащая эстетрольный компонент
UA123098C2 (uk) 2015-06-18 2021-02-17 Естетра Спрл Диспергована у порожнині рота одиниця дозування, що містить естетрольний компонент
CA3178291A1 (en) 2016-08-05 2018-04-12 Estetra Srl Method for the management of dysmenorrhea and menstrual pain
JP2021513507A (ja) * 2018-02-07 2021-05-27 エステトラ ソシエテ プリーヴ ア レスポンサビリテ リミテ 心臓血管系への影響を低減した避妊薬組成物
JOP20200260A1 (ar) 2018-04-19 2019-10-19 Estetra Sprl مركبات واستخداماتها للتخفيف من الأعراض المصاحبة لانقطاع الطمث
TWI801561B (zh) 2018-04-19 2023-05-11 比利時商依思特拉私人有限責任公司 化合物及其用於緩解絕經相關症狀的用途
HU231240B1 (hu) 2019-09-03 2022-04-28 Richter Gedeon Nyrt. Ipari eljárás nagytisztaságú ösztetrol hatóanyag előállítására
WO2023152682A1 (en) 2022-02-10 2023-08-17 Estetra Srl Contraceptive methods with scheduled bleeding effects

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3440320A (en) 1964-06-18 1969-04-22 Mortimer D Sackler Chelated suppository and method of using same
US3797494A (en) 1969-04-01 1974-03-19 Alza Corp Bandage for the administration of drug by controlled metering through microporous materials
DE2336433A1 (de) 1973-07-13 1975-04-03 Schering Ag 1.3-oxygenierte 8 alpha-oestratriene
DE2336434A1 (de) 1973-07-13 1975-04-17 Schering Ag 1.3-oxygenierte 8 alpha-oestratriene
DE2426779A1 (de) 1974-05-31 1975-12-18 Schering Ag 1.3-oxygenierte 8 alpha-oestratriene
US4722941A (en) 1978-06-07 1988-02-02 Kali-Chemie Pharma Gmbh Readily absorbable pharmaceutical compositions of per se poorly absorbable pharmacologically active agents and preparation thereof
US4460372A (en) 1981-02-17 1984-07-17 Alza Corporation Percutaneous absorption enhancer dispenser for use in coadministering drug and percutaneous absorption enhancer
US4573996A (en) 1984-01-03 1986-03-04 Jonergin, Inc. Device for the administration of an active agent to the skin or mucosa
US4624665A (en) 1984-10-01 1986-11-25 Biotek, Inc. Method of transdermal drug delivery
US4937238A (en) 1986-03-04 1990-06-26 The Board Of Regents Of The University Of Nebraska Prevention of mammary carcinoma
US4762717A (en) * 1986-03-21 1988-08-09 The General Hospital Corporation Continuous delivery of luteinizing hormone releasing hormone compositions in combination with sex steroid delivery for use as a contraceptive
US5223261A (en) 1988-02-26 1993-06-29 Riker Laboratories, Inc. Transdermal estradiol delivery system
US5043331A (en) 1989-06-15 1991-08-27 Orion-Yhtyma Oy Treatment of postmenopausal disorders
US5130137A (en) 1989-08-09 1992-07-14 The General Hospital Corporation Continuous delivery of luteinizing hormone releasing hormone compositions in combination with sex steroid delivery for use in treating benign ovarian secretory disorders
JPH04235171A (ja) 1990-07-26 1992-08-24 Sumitomo Chem Co Ltd スルホヒドロキサム酸誘導体、その製造法およびそれを有効成分とする除草剤
US5063507A (en) 1990-09-14 1991-11-05 Plains Cotton Cooperative Association Goods database employing electronic title or documentary-type title
US5211952A (en) * 1991-04-12 1993-05-18 University Of Southern California Contraceptive methods and formulations for use therein
US5340586A (en) 1991-04-12 1994-08-23 University Of Southern California Methods and formulations for use in treating oophorectomized women
US5340585A (en) 1991-04-12 1994-08-23 University Of Southern California Method and formulations for use in treating benign gynecological disorders
US5468736A (en) 1993-02-25 1995-11-21 The Medical College Of Hampton Road Hormone replacement therapy
US5895783A (en) 1993-07-16 1999-04-20 Schering Aktiengesellschaft Treatment of preeclampsia and preterm labor with combination of progestational agent and a nitric oxide synthase substrate and/or donor
NL9301562A (nl) 1993-09-09 1995-04-03 Saturnus Ag Preparaat voor substitutietherapie.
DE4344405C2 (de) 1993-12-24 1995-12-07 Marika Dr Med Ehrlich Ovulationshemmendes Mittel und Verfahren zur hormonalen Kontrazeption
WO1996003929A1 (en) 1994-08-04 1996-02-15 Biex, Inc. Method for prediction of premature delivery using estetrol (e4) as an indicator
DE4429374C1 (de) * 1994-08-12 1996-02-01 Jenapharm Gmbh Pharmazeutische Präparate zur Kontrazeption/Hormonsubstitution mit biogener Estrogenkomponente
ES2247710T3 (es) 1997-06-20 2006-03-01 Akzo Nobel N.V. Antagonista de gonadotropina.
DE19739916C2 (de) * 1997-09-11 2001-09-13 Hesch Rolf Dieter Verwendung einer Kombination aus einem Gestagen und einem Estrogen zur kontinuierlichen Ovulationshemmung und ggf. gleichzeitigen Behandlung und/oder Prophylaxe von Tumoren der Brustdrüsen
US6214815B1 (en) * 1998-12-23 2001-04-10 Ortho-Mcneil Pharmaceuticals, Inc. Triphasic oral contraceptive
DE19917930A1 (de) 1999-04-15 2000-10-19 Schering Ag Ent-Steroide als selektiv wirksame Estrogene
WO2000062753A1 (de) 1999-04-16 2000-10-26 Jenapharm Gmbh & Co. Kg Pharmazeutische oder kosmetische zusammensetzungen zur lokalen, intradermalen applikation von hormonen
WO2000073416A1 (en) 1999-05-28 2000-12-07 University Of Cincinnati Antisense oligonucleotides for fertility and menstrual cycle regulation and for chemopreventive and chemotherapeutic use
WO2001030356A1 (fr) 1999-10-25 2001-05-03 Laboratoire Theramex Composition hormonale a base d'un progestatif et d'un estrogene et son utilisation
US7371385B2 (en) 2000-05-12 2008-05-13 Oregon Health & Science University Method of treating immune pathologies with low dose estrogen
US6936599B2 (en) 2001-04-25 2005-08-30 The Regents Of The University Of California Estriol therapy for multiple sclerosis and other autoimmune diseases
EP1260225A1 (en) 2001-05-18 2002-11-27 Pantarhei Bioscience B.V. A pharmaceutical composition for use in hormone replacement therapy
WO2003041718A1 (en) * 2001-11-15 2003-05-22 Pantarhei Bioscience B.V. Use of estrogenic compounds in combination with progestogenic compounds in hormone-replacement therapy

Also Published As

Publication number Publication date
CA2448278A1 (en) 2002-11-28
NL301115I2 (nl) 2021-10-25
CA2448278C (en) 2010-06-08
PT1390042E (pt) 2008-03-10
US7732430B2 (en) 2010-06-08
LUC00213I2 (da) 2021-10-29
DE60223795D1 (de) 2008-01-10
EP1390042B1 (en) 2007-11-28
LUC00213I1 (da) 2021-07-08
NL301115I1 (da) 2021-07-14
DE60223795T2 (de) 2008-11-27
EP1390042A1 (en) 2004-02-25
CY1108093T1 (el) 2014-02-12
CY2021020I1 (el) 2021-12-31
CY2021020I2 (el) 2021-12-31
ES2296943T3 (es) 2008-05-01
WO2002094279A1 (en) 2002-11-28
FR21C1033I2 (fr) 2022-04-22
FR21C1033I1 (fr) 2021-10-15
US20040198710A1 (en) 2004-10-07

Similar Documents

Publication Publication Date Title
CY2021020I1 (el) Συστημα παραδοσης φαρμακων που αποτελειται απο τετραϋδροξυλιοποιημενο οιστρογονο για χρηση στην ορμονικη αντισυλληψη
DK1221919T3 (da) Oftalmisk lægemiddeladministrationsanordning
DE60140462D1 (de) Darreichungsform zur hormonalen kontrazeption
ES2525087T8 (es) Polvos basados en fosfolípidos para administración de fármacos
NO20000735L (no) Legemiddel leveringsanordning for vedvarende frigivelse
DK1473003T3 (da) Lægemiddeladministrationsanordning
NO20025568L (no) Stabile farmasöytiske lösningsformuleringer til anvendelse for utmålte doseinhalatorer
DE69819205D1 (de) Orale pharmazeutische dosierungsform beruhend auf stossweiser freisetzung
NO20041315L (no) Medikamentavleveringssystem
NO20022970D0 (no) Hydrogel-drevet medikamentdoseringsform
DK1158992T3 (da) Anvendelse af xenon til fremstilling af et farmaceutisk præparat til behandling af neurointoksikationer
NO20030627L (no) Hydrogel-drevet medikament doseringsform
DE69935681D1 (de) Vorrichtungen zur Medikamentverabreichung
ATE311173T1 (de) Neues selbstemulgierendes arzneistoffverabreichungssystem
NO20014738L (no) Tolperisonholdig farmasöytisk preparat for oral administrering
IL137559A0 (en) Transdermal drug delivery system
IL139177A0 (en) Sustained release drug delivery system
NO20026055D0 (no) Farmasöytisk komponent omfattende human paratyroidhormon og farmasöytisk komponent for nasal administrering inneholdende komponentene
IS7383A (is) Skammtaform með stýrða lyflosun til inngjafar
AU5654701A (en) Drug delivery mask
SG97918A1 (en) A novel drug delivery system: formulation for fat-soluble drugs
EP1438087A4 (en) SYSTEM FOR THE ADMINISTRATION OF A MEDICAMENTAL DELIVERY DEVICE
NO20022013L (no) Innretninger for transdermal legemiddellevering
AU2002311675A1 (en) Drug delivery system comprising a tetrahydroxylated estrogen for use in hormonal contraception
AU2002311676A1 (en) Drug delivery system comprising a tetrahidroxilated estrogen for use in hormonal contraception